Table 1. Baseline demographic and clinical characteristics of all subjects.
| Variables | N = 5,837 |
|---|---|
| Age (years) | 53.5 ± 7.9 |
| Age ≥ 40 years (%) | 96.5 |
| Sex, % male | 72.1 |
| BMI (kg/m 2 ) | 24.6 ± 3.0 |
| WC (cm) | 85.6 ± 8.4 |
| Systolic BP (mmHg) | 120.1 ± 13.3 |
| Diastolic BP (mmHg) | 76.8 ± 10.6 |
| Current smoker (%) | 23.7 |
| Moderate drinker (%) | 48.1 |
| Physically active (%) | 43.8 |
| Family history of diabetes (%) | 24.3 |
| Diabetes (n, %) | 750 (12.8) |
| Hypertension (n, %) | 1897 (32.5) |
| FPG (mg/dL) | 104.1 ± 20.3 |
| HbA1c (%) | 5.6 (5.3–5.9) |
| Total cholesterol (mg/dL) | 197.2 ± 33.2 |
| TG (mg/dL) | 109 (79–158) |
| LDL-C (mg/dL) | 123.3 ± 28.9 |
| HDL-C (mg/dL) | 53.5 ± 13.7 |
| Uric acid (mg/dL) | 5.6 ± 1.4 |
| AST (U/L) | 25 (21–31) |
| ALT (U/L) | 22 (16–31) |
| GGT (U/L) | 22 (15–37) |
| Number of Framingham risk factors | 1 (0–2) |
| 10-year Framingham risk score (%) | 6 (2–10) |
| 10-year ASCVD risk score (%) | 4.6 (2.0–8.9) |
| Significant stenosis (n, %) | 432 (7.4) |
| CACS | 0 (0–9) |
| CACS category | |
| 0 (n, %) | 3881 (66.7) |
| 1–100 (n, %) | 1406 (24.2) |
| 101–300 (n, %) | 347 (6.0) |
| >300 (n, %) | 185 (3.2) |
| Plaques | |
| Any plaque (n, %) | 2330 (39.9) |
| CAP (n, %) | 1535 (26.3) |
| NCAP (n, %) | 1047 (17.9) |
| MCAP (n, %) | 493 (8.4) |
BMI, body mass index; WC, waist circumference; BP, blood pressures; FPG, fasting plasma glucose; HbA1c, hemoglobin A1c; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma-glutamyl transferase; ASCVD, atherosclerotic cardiovascular disease; CACS, coronary artery calcium scores; CAP, calcified plaque; NCAP, noncalcified plaque; MCAP, mixed plaque.